Clinical trial
Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)
NCT06755008 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 19, 2025
- Completion date
- January 1, 2028
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.